The Bellipo record: every US IPO event and figure we cover, from the first public filing through life as a public company, each tied to the filing page it came from. Built for event-driven funds, data platforms and AI.
Book a demoAPI docs Coming soonWe read the filings so your pipeline doesn't have to. Every value comes back with its form, page, check date and version.
Final prospectus (424B4) · Aspen Neuroscience 9,375,000 Shares $15.00 per share Cover page · the live page shows the filing's exact text { "ticker": "ASPE", "event": "priced", "date": "2026-10-29", "price": 15.00, "shares": 9375000, "source": { "form": "424B4", "page": "cover" } }Use the record API to pull every IPO, event and figure as structured data, ready for a model, a screen or a spreadsheet.
No scraping, no PDF parsing, no guessing which filing is the latest. When a figure changes, the old value stays in the version history with the filing that changed it.
Book a demo How did Aspen Neuroscience's IPO price, and when did it first trade? Aspen Neuroscience priced at $15.00 per share, the bottom of its $15–$17 range, selling 9,375,000 shares[1]. It first traded on Nasdaq at 11:48 a.m. ET on Oct 30, 2026, at $14.70[2]. [1] 424B4 · cover page [2] Market data · first one-minute barThe ask API answers questions about any IPO on the record, and every number in the answer links to the filing page or market data behind it.
Built for AI agents and research tools that can't afford a number they can't trace.
Coming soon Biotech IPOs priced in October 2026| IPO | Range | Price | Raised | First trade |
|---|---|---|---|---|
| Bambusa Therapeutics | $15–$17 | $16.00 | $168.9M | 11:31 a.m. |
| Aspen Neuroscience | $15–$17 | $15.00 | $140.6M | 11:48 a.m. |
| City Therapeutics | $17–$19 | $18.00 | $200.0M | 11:59 a.m. |
Click a cell and the filing opens at the line it came from.
424B4 · cover pageBellipo reads every form in an IPO's life and pulls out the facts that matter, each one tied to the page it came from. You never have to open the filing.
19 SEC form types read, from the first filing to delisting 5 stages, from first filing to life as a public company 1 min first-trade time, to the minute RegistrationWe read
S-1 · F-1S-1/AFWPRWYou get
We read
424B4EFFECT8-ACERTYou get
We read
10-Q · 10-K8-K20-F · 6-KYou get
We read
Form 4 · 14413D · 13GForm 25You get
Space Exploration Technologies · final prospectus (424B4)
Dec 8, 2026 180th day after the prospectus. Up to 328.4M Class A shares are released, or up to 797.6M if earlier releases didn't happen. p. 260 After Q2 2027 results The extended lock-up ends on the second full trading day after results for the quarter ending June 30, 2027. p. 272Lock-up releases with share amounts, quiet periods, first prints and insider sales, each traceable to its filing.
Book a demo Event feed ET Oct 30 · 11:48 a.m. Aspen Neuroscience · first trade · $14.70 Market data Oct 30 · 11:31 a.m. Bambusa Therapeutics · first trade · $14.88 Market data Oct 29 Aspen Neuroscience · priced · $15.00 · 9,375,000 shares 424B4 Oct 26 Aspen Neuroscience · terms set · $15–$17 S-1/A Oct 16 · 11:59 a.m. City Therapeutics · first trade · $23.00 Market data Oct 9 Aspen Neuroscience · filed to go public S-1A clean IPO feed for your users, with sources you can show them and a history you can audit.
Book a demo Record API Sample GET /v1/ipos/ASPE/events [ { "event": "priced", "date": "2026-10-29", "price": 15.00, "shares": 9375000, "source": "424B4, cover" }, { "event": "first_trade", "date": "2026-10-30", "time": "11:48 a.m. ET", "price": 14.70, "source": "market data" } ]IPO data your models can cite, not just repeat. Every answer grounded in a filing page.
Book a demoThe filing, the page and the date it was checked, on every figure.
Every change is dated and kept, with the filing that changed it.
What you ask and pull is never used to train any model.
We're opening the record to a small group of funds, platforms and AI teams before general release. Partners shape the fields and delivery, and get early access to the API.